No Relevant Relationship between Glucose Variability and Oxidative Stress in Well-Regulated Type 2 Diabetes Patients
Open Access
- 1 January 2011
- journal article
- research article
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 5 (1) , 86-92
Abstract
Background: A strong relationship between glycemic variability and oxidative stress in poorly regulated type 2 diabetes (T2DM) on oral medication has been reported. However, this relationship was not seen in type 1 diabetes. The purpose of this study is to reexamine the relation between glycemic variability and oxidative stress in a cohort of T2DM patients on oral medication. Methods: Twenty-four patients with T2DM on oral glucose lowering treatment underwent 48 hours of continuous glucose monitoring (CGMS® System Gold™, Medtronic MiniMed) and simultaneous collection of two consecutive 24-hour urine samples for determination of 15( S )-8-iso-prostaglandin F 2α (PGF 2α ) using high-performance liquid chromatography tandem mass spectrometry. Standard deviation (SD) and mean amplitude of glycemic excursions (MAGE) were calculated as markers of glycemic variability. Results: Included in the study were 66.7% males with a mean age (range) of 59 (36–76) years and a mean (SD) HbA1c of 6.9% (0.7). Median [interquartile range (IQR)] urinary 15( S )-8-iso-PGF 2α excretion was 176.1 (113.6–235.8) pg/mg creatinine. Median (IQR) SD was 31 (23–40) mg/dl and MAGE 85 (56–106) mg/dl. Spearman correlation did not show a significant relation for SD (ρ = 0.15, p = .49) or MAGE (ρ = 0.23, p = .29) with 15( S )-8-iso-PGF 2α excretion. Multivariate regression analysis adjusted for age, sex, HbA1c, and exercise did not alter this observation. Conclusions: We did not find a relevant relationship between glucose variability and 15( S )-8-iso-PGF 2α excretions in T2DM patients well-regulated with oral medication that would support an interaction between hyperglycemia and glucose variability with respect to the formation of reactive oxygen species.Keywords
This publication has 21 references indexed in Scilit:
- A randomized clinical trial comparing the effect of basal insulin and inhaled mealtime insulin on glucose variability and oxidative stressDiabetes, Obesity and Metabolism, 2009
- Quantification of urinary 8-iso-PGF2α using liquid chromatography-tandem mass spectrometry and association with elevated troponin levelsClinical Biochemistry, 2007
- Should minimal blood glucose variability become the gold standard of glycemic control?Journal of Diabetes and its Complications, 2005
- Factors Regulating Isoprostane Formation In VivoAntioxidants & Redox Signaling, 2005
- Biochemistry and molecular cell biology of diabetic complicationsNature, 2001
- Measurement of F2-isoprostanes as an index of oxidative stress in vivoFree Radical Biology and Medicine, 2000
- Measurement of Urinary F2-Isoprostanes as Markers of in Vivo Lipid Peroxidation—A Comparison of Enzyme Immunoassay with Gas Chromatography/Mass SpectrometryAnalytical Biochemistry, 1999
- In Vivo Formation of 8-Iso-Prostaglandin F2αand Platelet Activation in Diabetes MellitusCirculation, 1999
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976